UMR MEMBERS DEPLOY BIOMEDICAL INNOVATION TO FIGHT COVID-19

Experts explain why recruiting clinical trial participants from diverse backgrounds around the world—young, old, Black, brown, Indigenous and more—is critical to developing a potential COVID-19 vaccine, in this bonus clip from “The Road to a Vaccine.”

A doctor at UPenn is using her platform to raise awareness about inequities in health care and show the community the COVID-19 vaccine is safe.

By the end of the week, drug maker Johnson and Johnson is expected submit its COVID-19 vaccine to the FDA for emergency use authorization.

Johnson & Johnson Chief Scientific Officer Dr. Paul Stoffels, Harvard’s Dr. Dan Barouch and others discuss where we are in the fight against COVID-19 and learn what’s next for vaccine development. Plus, other news with Dr. Uché Blackstock.

On CNBC’s Mad Money With Jim Cramer, Thermo Fisher Scientific CEO Marc Casper explained his outlook for the necessity of coronavirus vaccines and therapies as the country continues to battle the pandemic.

In an interview with ABC News, Dr. Dan Barouch, a researcher who helped develop the Johnson & Johnson vaccine, breaks down the vaccine’s efficacy and how new variants complicated its development.

The pioneering work for the Moderna COVID-19 vaccine, which was granted emergency use authorization by the FDA, and the Pfizer vaccine began at the University of Pennsylvania more than a decade ago.

The coronavirus is changing much faster than scientists had expected, which could ultimately make it much harder to contain. But at Stanford University, a new effort is underway to help track these tricky variants in our community, which are already spreading in other parts of the world.

Listen to the year’s most popular episodes of the Breakthroughs podcast, featuring Northwestern Medicine experts discussing COVID-19 research.

Social and economic inequality has made minority communities more prone to contracting SARS-COV-2; the virus that causes COVID-19. One of those severely affected is the black community in the United States. On this episode of Science With a Twist, Fred Lowery, Senior Vice President and President of Life Sciences Solutions and Laboratory Products at Thermo Fisher Scientific, interviews Dr. James Hildreth, American immunologist and academic administrator. Fred and James discuss the “Just Project”‚ a multipronged effort to help address the coronavirus crisis, which has disproportionately impacted communities of color.

This episode of Show Me the Science contrasts the rapid development of effective vaccines with the lack of progress toward effective therapies.

Scientists expected there could be new versions of COVID-19, known as variants. But what scientists at the University of Pennsylvania want to know is: will the two vaccines work against them as well?

Research has found a specific kind of heart disease in people who have recovered from COVID-19. Myocarditis can cause serious complications, including in athletes. Dr. Haider Warraich, a cardiologist and researcher at Brigham and Women’s Hospital and Harvard Medical School, joins CBSNews AM to talk more about the illness.

NPR‘s Ari Shapiro talks with Dr. Steven Goodman of the Stanford School of Medicine about the ethical question of whether COVID-19 vaccine trials should be unblinded.

Microbiologist Susan Weiss, Ph.D. has been studying coronaviruses for four decades and is now co-director of Penn′s Center of research on coronavirus and other emerging pathogens. As for this new variant, she says there is still a lot to learn and as to whether it makes the virus spread faster, that hasn′t been scientifically proven yet.

A study of how 98 million Americans move around each day suggests that most infections occur at “superspreader” sites that put people in contact for long periods, and details how mobility patterns help drive higher infection rates among minority and low-income populations.

FOX Business’ Edward Lawrence provided details to on how Thermo Fisher Scientific is building cold-storage freezers to store the future coronavirus vaccine at various points of the supply chain at their site in Asheville, N.C.

Dr. Lloyd Minor, Stanford Medicine Dean, joins ‘Squawk on the Street’ to discuss the hospital’s distribution plan for Pfizer’s coronavirus vaccine and more.

Ron O’Brien speaks with Dr. Stephen Young, an expert in Microbiology, with a background in pathology, virology, and infectious diseases. They discuss what we should know during the potential viral storm produced by the collision of the seasonal flu and the COVID-19 pandemic.

Dr. Nancy Messonnier leads the Centers for Disease Control and Prevention’s work to safely vaccinate the country. Whether the question is who to vaccine first, how to restore trust, or how to administer two doses of a vaccine stored at -70 degrees to a nation of 328 million people, she’s got the answers.

President and CEO of Biotechnology Innovation Organization Dr. Michelle McMurry-Heath weighs in on America‘s News HQ.

Researchers from Northwestern University estimate food insecurity in America doubled in the first few months after the coronavirus arrived, and a recent CBS News poll shows more than one third of Americans are at least somewhat concerned they won‘t have enough money for groceries in the next year.

COVID threatens those whose immune systems can’t make enough neutralizing antibodies to fight off the viral invaders. But what if scientists could make super-potent antibodies in the lab and infuse them into newly infected patients? That’s exactly what the first FDA-authorized coronavirus antibody treatment has achieved. Its maker, Eli Lilly, has generated clinical evidence that their therapy can significantly reduce COVID hospitalization rates when taken early.

Americans suffering from Alzheimer’s disease and dementia are battling COVID-19 threats and the dangers of isolation.

As the world continues to cope with the COVID-19 pandemic, flu season has arrived once again. Watch Lisa Maragakis, senior director of infection prevention at the Johns Hopkins Health System and infectious diseases physician at The Johns Hopkins Hospital, and Aaron Milstone, associate hospital epidemiologist and pediatric infectious diseases specialist at Johns Hopkins Children’s Center, as they answer your questions about the flu and COVID-19.

How Boston University engineers built a 6,000-test-per-day system from scratch.

U.S. coronavirus cases have set a new single daily record, at more than 131,000. Dr. Lloyd Minor, Stanford University School of Medicine dean, joins ‘Power Lunch’ to discuss what tactical measures can be taken to help control the spread and the concerns surrounding a Covid-19 vaccine.

Lisa Ling speaks to Dr. Uché Blackstock about the racial inequities the pandemic has exposed, Dr. Alison Schwartz about battling a COVID-19 spike in Wisconsin and 14-year-old Anika Chebrolu about her prize-winning potential coronavirus therapy.

As the need grows for COVID-19 testing, so does a need to find a way to produce faster results. Engineers at Stanford think they’ve come up with an answer.

New video shows the first injection as Stanford doctors start phase three of the Johnson and Johnson COVID-19 vaccine trial. This phase three trial will be done at 180 sites around the world with 60,000 participants, 1,000 of them at Stanford. It’s a double-blind study, meaning some will get active vaccine while others will get a placebo. They’ll all be monitored.

View the full webinar from the October 13th, 2020 virtual event, featuring: Dr. Jamila Michener discussing the connection between racial disparities, COVID-19 and Medicaid; Dr. Alpa Patel sharing research from the American Cancer Society about the impact social determinants of health have on cancer patients; and Mike Perry sharing preliminary results from new messaging and polling research about race, health and the pandemic.

Overcrowded hospitals during the pandemic can pose treatment challenges for patients with other serious illnesses. As Kite Pharma CEO Christi Shaw says, “Cancer doesn’t stop in a crisis.” Neither do her company‘s employees, who go to extraordinary lengths to get personalized CAR-T treatments to patients around the world.

Vanderbilt University released an updated analysis of a previous report on COVID-19 in Tennessee. Tuesday‘s report shows areas without mask requirements have a larger increase in COVID-19 hospitalizations.

This episode of ‘Show Me the Science’ highlights an effort led by Washington University scientists to use computing power from around the world to identify vulnerabilities in the coronavirus.

Bloomberg School’s Ellen MacKenzie spoke with the nation’s top infectious diseases expert in the first installment of the university’s Health Policy Forum series. The series is jointly sponsored by the schools of Medicine, Nursing, and Public Health, and the Carey Business School. It is designed to bring together JHU faculty, students, and operational experts with policymakers to explore the development and implementation of health policy interventions.

This episode of Show Me the Science focuses on a saliva test developed by School of Medicine scientists to detect the virus that causes COVID-19.

In this bonus clip from Johnson & Johnson’s weekly live series, The Road to a Vaccine, we touch on the topic of why you should trust science now more than ever. Watch as health experts explain how focusing on science is crucial to ending the COVID-19 pandemic—and why the stakes in the U.S.

Nicholas Adams, research assistant professor of biomedical engineering, discusses what testing for the COVID-19 might look like as we enter cold and flu season.

Dr. Megan Collins, Assistant Professor of the Johns Hopkins Berman Institute of Bioethics, discusses safely reopening schools amid the pandemic on the Bloomberg Businessweek Podcast.

Ron O’Brien speaks with Mary Kay Bates, Senior Cell Culture Scientist at Thermo Fisher Scientific. Mary gives us an inside look into the complex world of vaccine development and why developing one for COVID-19 has been so different.

NPR`s Lulu Garcia-Navarro speaks to Harvard researcher Dr. Jose Figueroa about how COVID-19 disproportionately impacts Black and Latino communities, and how policy makers could address those issues.

Three hundred new workers at the Thermo Fisher factory in Lenexa are making shipping tubes they’ll use to send COVID tests to the labs.

As the fight to research and develop innovative treatments and vaccines advances, three biopharmaceutical scientists share what they have in common: combatting COVID-19.

This episode of ‘Show Me the Science‘ details research findings that patients with COVID-19 often develop weakened rather than hyperactive immunity in response to the coronavirus.

In this video, The Brink goes behind the scenes at Boston University’s Kilachand Center for Integrated Life Sciences & Engineering to see how scientists are safely returning to the lab.

A team of Northwestern scientists have come together from across disciplines to develop a COVID-19 antibody test designed for at-home use. Elizabeth McNally, MD, PhD, is part of the team working on this test to determine prior exposure to the virus.

In this video, watch BU graduate researcher Jessie Song 3D print prototypes of alternative nasopharyngeal swabs, which could help bridge the supply shortage caused by global demands for coronavirus testing.

Michelle Williams, Dean of Harvard’s T.H. Chan School of Public Health, joins CNBC’s “Squawk Box” for a closer look at how schools are grappling with how to safely reopen.

Johns Hopkins Assistant Professor of Emergency Medicine Lauren Sauer discusses understanding how antibody production works in the fight against Covid-19. She speaks with Bloomberg’s Francine Lacqua.

Dr. Scott Atlas, a former chief of neuroradiology at Stanford University Medical Center and a senior fellow at Stanford’s Hoover Institution joined the Daily Caller’s Stephanie Hamill to share his views on the reopening of schools in the fall amid the coronavirus pandemic.

University of Pennsylvania School of Nursing faculty member and LDI Senior Fellow Adriana Perez conducts research in two of the Philadelphia area’s largest Latino communities. She provides insights into how COVID-19 is impacting each.

Although COVID-19 doesn’t necessarily discriminate, some communities are far more susceptible to the disease. People who are black or African-American are more likely to contract the virus – and to die from it. Clyde Yancy, MD, discusses reasons for these outcomes and the need to fully address health care disparities in America.

Hundreds of thousands of people are being tested for SARS-CoV-2 (COVID-19) around the world and the tests themselves are a crucial starting point in efforts to flatten the spread of the virus. This episode of Thermo Fisher Scientific’s Science with a Twist podcast talks with Senior Director of Genetic Sciences, Joshua Tratta who explains how tests are created, how they’re performed and how they’re analyzed.

While the coronavirus pandemic has changed many things around the world, it has not stopped child development. In this series of special episodes of The Brain Architects – a podcast from the Center on the Developing Child at Harvard University – we aim to share helpful resources and ideas in support of all those who are caring for children while dealing with the impacts of COVID-19.

This is the only podcast at the intersection of biotechnology, politics, patients and the planet. We spotlight next-generation breakthroughs, the people they help, the global problems they solve and politicians with the power to fast-track a better future or mess it all up. Hosted by former Congressman Jim Greenwood. Current episodes look at COVID-19 from a variety of different angles.

Listen to this special series of Stanford Engineering’s The Future of Everything podcast to learn how researchers from across the university are bringing their insights and knowledge to address the challenges of COVID-19.

As the Coronavirus continues to spread, doctors, scientists and health agencies are racing to contain the outbreak.

In this episode of Thermo Fishers Science with a Twist podcast, hear how they are using scientific technologies to detect, prevent and develop a vaccine for this respiratory syndrome.

Vanderbilt University faculty are sharing their expertise on a range of topics related to COVID-19. Subscribe to Vanderbilt’s “Ask an Expert” series on YouTube to get the latest updates.

TIME speaks with Christopher Gill, MD, an associate professor of global health at Boston University School of Public Health, about the ways the COVID-19 virus can spread human to human, whether the virus is airborne, and if transmission makes a difference indoors versus outdoors.

Johns Hopkins University Professor of Nursing Jason Farley explains the timeline for vaccine testing and the dangers of a second wave of coronavirus infections later in the year during cold and flu season. He speaks on “Bloomberg Surveillance.”

Hosted by prominent journalist Lisa Ling, Johnson & Johnson’s social-first show titled The Road to a Vaccine series features interviews with scientists, global health leaders and other experts on the COVID-19 front lines to reveal the latest medical advances and collaborations to create a coronavirus vaccine—and hopefully a return to a world without the pandemic.

Just as you are doing your part to fight the novel coronavirus, America’s Biopharmaceutical Companies are working around the clock to fight COVID-19. Click to watch video.

Stanford University’s Freeman Spogli Institute for International Studies (FSI) senior fellows Karen Eggleston and David Relman join host Michael McFaul to discuss what you should know about COVID-19 and its impact on the world.

With the number of COVID-19 cases climbing daily, some doctors and researchers are looking to bring back a very old therapy: the transfusion of antibodies from the plasma of recovered COVID-19 patients into patients battling COVID-19 infection.

In this episode, Jeffrey P. Henderson, MD, PhD, an associate professor in the Division of Infectious Diseases, discusses the effort to test plasma as a way to treat very ill patients.

Amplify Nursing is a Penn Nursing podcast supported by the Pinola Fund for Innovation in Nursing.

Episodes highlight the breadth and depth of nursing influence on society by amplifying nurses who are pushing boundaries and breaking down barriers to build a new paradigm.

Experts from the Johns Hopkins Bloomberg School of Public Health offer science and evidence-based insights on the public health news of the day. The current focus is the novel coronavirus spreading around the world.

The outbreak of a novel coronavirus in China is making headlines around the world. In this podcast produced by Northwestern’s Feinberg School of Medicine, microbiologist Karla Satchell, PhD, is leading an effort to investigate the structure biology of the components of the virus to ultimately understand how to stop it from replicating in human cells through a medication or vaccine.

What does COVID-19 mean for cancer patients and caregivers? How can they lower their risk of infection? How can everyone help reduce risk for this vulnerable population? What should cancer patients do if they are undergoing treatment?

American Cancer Society-funded scientists discuss the most critical questions in cancer research and recent challenges posed by COVID-19 pandemic.

As COVID-19 continues to push unprecedented challenges on medical communities, one of the most pressing threats for hospital staff across the country is a dwindling supply of ventilators.

In this video, an interdisciplinary team of Vanderbilt University and Vanderbilt University Medical Center faculty show how to use common materials to build a ventilator.